Summary of Key Information:
Nature of Filing / Announcement: Outcome of Board Meeting under Regulation 30 of SEBI LODR Regulations
Date of Board Meeting / Approval: Saturday, 13 June 2026
Meeting Time: Commenced at 10:30 AM and concluded at 12:45 PM
Corporate Actions:
Preferential Warrant Issuance:
- The Board approved creation, offer, issue and allotment of 77,02,182 (Seventy-Seven Lakh Two Thousand One Hundred And Eighty-Two) warrants
- Each warrant is fully convertible into 1 fully paid-up equity share of face value ₹2 each
- Warrant Issue Price: ₹779.00 per warrant (including premium of ₹777.00 each)
- Total consideration: ₹599,99,99,778/- (Five Hundred Ninety-Nine Crore Ninety-Nine Lakh Ninety-Nine Thousand Seven Hundred And Seventy-Eight Only)
- Conversion period: 18 months from date of allotment
- Payment terms: 25% payable at subscription, 75% payable at conversion
Allottee Details:
| Sr. No. | Name | Category | Number of Warrants | Aggregate Consideration (₹) |
| 1. | Dr. Abhinay Bollineni | Promoter | 32,09,242 | ₹2,49,99,99,518/- |
| 2. | Mr. Adwik Bollineni | Promoter | 32,09,242 | ₹2,49,99,99,518/- |
| 3. | Bharas Ventures LLP | Promoter Group | 12,83,698 | ₹1,00,00,00,742/- |
| Total | | | 77,02,182 | ₹5,99,99,99,778/- |
Shareholding Impact (assuming 100% conversion):
- Dr. Abhinay Bollineni: Pre-issue 2,36,495 shares (0.06%) → Post-issue 34,45,737 shares (0.84%)
- Mr. Adwik Bollineni: Pre-issue 40,640 shares (0.01%) → Post-issue 32,49,882 shares (0.80%)
- Bharas Ventures LLP: Pre-issue NIL shares → Post-issue 12,83,698 shares (0.31%)
- Total Promoter & Promoter Group: Pre-issue 13,64,89,330 shares (34.11%) → Post-issue 14,41,91,512 shares (35.35%)
Extraordinary General Meeting:
- EGM approved for 09 July 2026 through video conferencing
- Purpose: To seek shareholder approval for the preferential warrant issuance
Regulatory Compliance:
- Relevant Date for pricing: Tuesday, 09 June 2026
- Price determined as per Regulation 164 of SEBI ICDR Regulations and company's articles of association
- Based on valuation report from registered valuer
- Subject to shareholder and regulatory approvals
Additional Terms:
- Warrants can be exercised in one or more tranches
- If not exercised within 18 months, entitlement expires and paid amounts are forfeited
- Nature of consideration: Cash